253 related articles for article (PubMed ID: 9834077)
1. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.
Soos JM; Morrow J; Ashley TA; Szente BE; Bikoff EK; Zamvil SS
J Immunol; 1998 Dec; 161(11):5959-66. PubMed ID: 9834077
[TBL] [Abstract][Full Text] [Related]
2. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
3. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation.
Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS
Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775
[TBL] [Abstract][Full Text] [Related]
4. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
5. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions.
Matsumoto Y; Ohmori K; Fujiwara M
Immunology; 1992 Jun; 76(2):209-16. PubMed ID: 1378815
[TBL] [Abstract][Full Text] [Related]
6. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes.
Sun D; Wekerle H
Nature; 1986 Mar 6-12; 320(6057):70-2. PubMed ID: 2419764
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong Y; Rohn WM; Benveniste EN
J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
[TBL] [Abstract][Full Text] [Related]
8. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
9. Lewis rat T cells can reutilize, process, and present myelin basic protein to antigen-specific T cell lines.
St Louis JM; Pasick JM; Stein C; Freeman D; Singh B; Dales S; Strejan GH
Cell Immunol; 1994 Jun; 156(1):36-53. PubMed ID: 7515332
[TBL] [Abstract][Full Text] [Related]
10. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
11. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1.
Bourdoulous S; Béraud E; Le Page C; Zamora A; Ferry A; Bernard D; Strosberg AD; Couraud PO
Eur J Immunol; 1995 May; 25(5):1176-83. PubMed ID: 7539749
[TBL] [Abstract][Full Text] [Related]
12. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
13. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.
Slavin AJ; Soos JM; Stuve O; Patarroyo JC; Weiner HL; Fontana A; Bikoff EK; Zamvil SS
J Clin Invest; 2001 Oct; 108(8):1133-9. PubMed ID: 11602620
[TBL] [Abstract][Full Text] [Related]
14. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
[TBL] [Abstract][Full Text] [Related]
15. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
16. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
[TBL] [Abstract][Full Text] [Related]
17. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation.
Aloisi F; Ria F; Penna G; Adorini L
J Immunol; 1998 May; 160(10):4671-80. PubMed ID: 9590212
[TBL] [Abstract][Full Text] [Related]
18. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
[TBL] [Abstract][Full Text] [Related]
19. T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein.
Zamvil SS; Mitchell DJ; Moore AC; Schwarz AJ; Stiefel W; Nelson PA; Rothbard JB; Steinman L
J Immunol; 1987 Aug; 139(4):1075-9. PubMed ID: 2440944
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis.
Suter T; Malipiero U; Otten L; Ludewig B; Muelethaler-Mottet A; Mach B; Reith W; Fontana A
Eur J Immunol; 2000 Mar; 30(3):794-802. PubMed ID: 10741394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
